The Radiopharmaceuticals Market Size was valued at USD 5.07 billion in 2022, and is expected to reach USD 10.26 billion by 2030, and grow at a CAGR of 9.2% over the forecast period 2023-2030.

The radiopharmaceuticals market is experiencing significant growth and is expected to continue expanding in the coming years. Radiopharmaceuticals are specialized drugs that contain radioactive substances, used for diagnostic and therapeutic purposes in nuclear medicine. They play a crucial role in the diagnosis and treatment of various diseases, including cancer, cardiovascular disorders, and neurological conditions.

Get Free PDF Sample Report: https://www.snsinsider.com/sample-request/1070

One of the key factors driving the growth of the radiopharmaceuticals market is the increasing prevalence of chronic diseases worldwide. As the global population continues to age and lifestyles become more sedentary, there has been a surge in chronic conditions such as cancer and cardiovascular diseases. Radiopharmaceuticals offer a non-invasive and highly accurate method for diagnosing these diseases at an early stage, enabling timely intervention and improved patient outcomes.

Moreover, advancements in imaging technologies have further propelled the demand for radiopharmaceuticals. Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) are widely used.

KEY MARKET SEGMENTS

By Radioisotope Type

  • Technetium-99
  • Fluorine-18
  • Iodine-131
  • Leutetium-177
  • Yttrium-90
  • Gallium-68
  • Gallium-67
  • Rubidium-82
  • Iodine-123
  • Iodine-125
  • Indium-111
  • Others

By Source 

  • Cyclotrons
  • Nuclear Reactors

By Application

  • Neurology
  • Cardiology
  • Oncology
  • Gastroenterology
  • Nephrology
  • Neuroendocrinology
  • others

By End-User

  • Hospital & Clinics
  • Diagnostic Center 
  • Ambulatory Surgical Centers
  • Cancer Research Institute
  • Others

Major Players Listed in the Report are as Follows:

GE healthcare, Jubilant life sciences, Curium, JSC isotopes,  Novartis AG,  Bracco diagnostic,  Cardinalhealth, Norgine B.V, Siemens healthiness, Curium,  Lantheus Medical imaging, Australian Nuclear Science and Technology and Other Players

Other Report

Active Pharmaceutical Ingredient Market Growth

3D Printed Wearables Market Growth

3D Cone Beam CT System Market Growth

About US:

SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.

We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.

Contact Us:

Akash Anand – Head of Business Development & Strategy,

[email protected],

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)